Related Experiment Video
Updated: May 20, 2026

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
Severe Plasmodium vivax malaria among sudanese children at New Halfa Hospital, Eastern Sudan
Insights
Severe Plasmodium vivax malaria is a recognized condition in eastern Sudan, affecting children with various critical symptoms. Further research is needed to understand its emergence and impact.
Area of Science:
- Malariology
- Tropical Medicine
- Pediatric Infectious Diseases
Background:
- Limited published data exists on severe Plasmodium vivax malaria cases in Africa.
- Plasmodium vivax malaria is increasingly recognized beyond its traditionally endemic regions.
Purpose of the Study:
- To describe the clinical patterns and manifestations of severe Plasmodium vivax malaria in children.
- To document the incidence and types of severe complications in pediatric patients with P. vivax malaria in eastern Sudan.
Main Methods:
- A descriptive study was conducted at New Halfa Hospital in Sudan.
- Data was collected on children admitted with severe P. vivax malaria between September 2009 and December 2011.
Main Results:
- Eighteen children were admitted with severe P. vivax malaria during the study period.
- Common manifestations included severe anemia (33.3%), jaundice (27.8%), and thrombocytopenia (22.2%).
- Other severe conditions observed were hypotension, cerebral malaria, epistaxis, renal impairment, and hypoglycemia.
Conclusions:
- Severe Plasmodium vivax malaria is an existing and significant entity in eastern Sudan.
- The findings highlight the need for further research into the emergence and clinical spectrum of severe P. vivax malaria in this region.
Background:
There are few published reports on severe Plasmodium vivax malaria in Africa.
Methods:
Clinical pattern/manifestations of severe P. vivax were described in children admitted at New Halfa Hospital in Sudan between September 2009-December 2011.
Results:
Eighteen children were admitted at the hospital during the study period with different manifestations of severe P. vivax malaria namely: severe anaemia (6, 33.3%), jaundice (5, 27.8%), thrombocytopenia (4, 22.2%), hypotension (3, 16.7%), cerebral malaria (2, 11.1%), epistaxis (2, 11.1%), renal impairment (1, 5.5%), hypogylcaemia and more than one manifestation (5, 27.8%).
Conclusion:
Severe P. vivax malaria is an existing entity in eastern Sudan. Further studies are required to understand emergence of severe P. vivax malaria.
More Related Videos
Related Concept Videos
Symbiosis
Pharmacokinetics in Pediatric Patients: Drug Excretion

